The tirzepatide 90mg pen: clearing up a common mix-up

Why '90mg tirzepatide' doesn't exist, and why that's worth knowing

The biggest misconception behind this search is that 90mg represents a higher or stronger version of Mounjaro, perhaps a once-monthly mega-dose or a bulk pen. It isn't. The six licensed strengths top out at 15mg per weekly dose, giving a maximum of 60mg across a four-dose pen. A 90mg pen would exceed that by half again, a formulation that has never been approved by the MHRA, never appeared in the SURMOUNT clinical programme, and doesn't exist in any legitimate UK supply chain.

Where does the figure come from? Most often it appears in listings from unregulated online sellers, sometimes as a misprinted or deliberately inflated number designed to look like a premium product. The NHS medicines page for tirzepatide sets out the actual strengths clearly. If a seller is offering a pen that isn't on that list, that's a red flag, full stop. The MHRA has also published warnings about counterfeit weight-loss pens sold without a prescription, some containing harmful substances. Report any suspect seller through the Yellow Card scheme.

A quick check takes under a minute: find the pharmacy on the GPhC register using the pharmacy's name or registration number. If it isn't listed, walk away.

The actual pen strengths, and the logic behind titration

Mounjaro's six UK strengths are 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg. Each pre-filled KwikPen contains four doses at the same strength, giving one month of treatment per pen. Treatment starts at 2.5mg, not as a therapeutic dose, but to let your system adjust to the medicine before stepping up. The first pen's job is settling in, not weight loss. From there a prescriber moves the dose up roughly every four weeks, assessing tolerance and response at each stage.

The 15mg pen is the maximum. In SURMOUNT-1, which randomised 2,539 adults with obesity over 72 weeks, participants on 15mg tirzepatide achieved an average body-weight reduction of around 20–21%, a figure the NICE appraisal of tirzepatide (TA1026) took into account when recommending the medicine. Those results came from a licensed, prescribed, titrated protocol, not from an unlicensed high-dose pen. You can read more about the full pen range on the tirzepatide pens overview.

Dose increases aren't automatic. A prescriber reviews each patient before moving up, which is why clinical oversight isn't a formality, it's the mechanism that makes the medicine safer and more effective. If you're currently on treatment and unsure where your dose sits, the guide to using the tirzepatide pen correctly covers what to look for on the pen label.

What sellers offering unlicensed pen strengths are actually selling

A tirzepatide pen labelled 90mg isn't a stronger version of Mounjaro. It's either mislabelled, counterfeit, or a compounded product manufactured outside the licensed supply chain. Compounded tirzepatide is not approved by the MHRA for use in the UK; it bypasses the safety and quality standards built into the manufacturing process for the genuine KwikPen.

The practical risks are real. Counterfeit weight-loss pens seized in the UK have contained incorrect active substances, wrong concentrations, and in some cases no active ingredient at all. Large seizures of fake pens have been made in recent years, and the MHRA has escalated enforcement significantly. Buying from an unverified source on the basis of a lower price or an unusual strength puts you at the sharp end of that problem.

If you're exploring tirzepatide for weight management, the safe route is a prescription from a registered prescriber, dispensed by a GPhC-registered pharmacy sourcing from the licensed UK supply chain. The Mounjaro overview page explains how the medicine works and what the assessment process involves. For a broader look at weight loss treatment options, including eligibility criteria and how private prescribing works, that's a good place to start.

How tirzepatide is prescribed and dispensed through a regulated UK pharmacy

The only legal route to Mounjaro in the UK is a prescription, issued after a clinical assessment by a registered prescriber. At a private pharmacy like nume, that means a consultation reviewed the same day by a GPhC-registered Independent Prescriber, a clinician, not software, reading your answers and making a clinical judgement. There are no shortcuts, and no pen strength is selected by the patient.

Once approved, treatment is dispatched the same day (for orders in before 12pm, Monday to Friday) and delivered free the next working day by DPD, in plain unbranded packaging. The specific pen strength dispensed reflects what the prescriber has determined is clinically appropriate for that stage of your treatment. If you're transferring from another provider at a higher dose, evidence of your current treatment is required before any continuation is confirmed. You can find out how the tirzepatide pen is structured and what each dose stage involves before your consultation, and if you're approaching the upper end of titration, the pages covering the tirzepatide 30mg pen and the tirzepatide 60mg pen explain what those later stages look like in practice. Our clinical team is available for questions through aftercare seven days a week. When you're ready, check your eligibility and start your free consultation.